Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/24/2025

Managing Cephalexin-Induced Nausea and Vomiting in Children

Immediate Non-Pharmacologic Interventions

  • The Centers for Disease Control and Prevention recommends ensuring adequate hydration before and during antibiotic therapy, and administering small, frequent volumes of oral rehydration solution to reduce gastrointestinal irritation and facilitate hydration 1
  • The Centers for Disease Control and Prevention suggests continuing breast-feeding on demand for infants, or providing full-strength formula for bottle-fed infants to maintain nutrition and hydration 1

Pharmacologic Antiemetic Therapy

  • The American Academy of Pediatrics recommends ondansetron as the preferred antiemetic for pediatric patients due to its superior efficacy and safety profile compared to alternatives like metoclopramide 2, 3, 4
  • The American Academy of Pediatrics suggests administering ondansetron at a dose of 0.15 mg/kg per dose (maximum 16 mg) via the oral route, and exercising special caution in children with underlying heart disease due to potential QT interval prolongation 2, 3, 4
  • The American Society of Clinical Oncology recommends dexamethasone as an adjunctive therapy to improve antiemetic efficacy when combined with other antiemetics, particularly in severe or refractory cases 5, 6, 7

Medications to Avoid

  • The American Academy of Pediatrics advises against using metoclopramide for multiple consecutive days in pediatric patients due to the high incidence of dystonic reactions and extrapyramidal symptoms 3

Clinical Decision Algorithm

  • The Centers for Disease Control and Prevention recommends modifying cephalexin administration by giving with food and ensuring adequate hydration as the first step in managing cephalexin-induced nausea and vomiting 1
  • The American Academy of Pediatrics suggests administering ondansetron 0.15 mg/kg (maximum 16 mg) after screening for cardiac contraindications as the second step in managing cephalexin-induced nausea and vomiting 2, 4

Important Caveats

  • The American Academy of Pediatrics emphasizes that antiemetic treatment should not replace appropriate fluid and electrolyte therapy, which remains the mainstay of management 4
  • The Centers for Disease Control and Prevention notes that gastrointestinal symptoms from cephalexin are typically mild and self-limiting, and considers whether the infection itself may be contributing to nausea and vomiting 1